Table 5.
Comparative analysis of all measured variables for the EG and the CG at the final assessment.
| Parameter | Group | Med | IQR | Min | Max | Sk. | Z | p | r |
|---|---|---|---|---|---|---|---|---|---|
| EPIC-26 (overall urinary difficulties) | CG | 5 | 1 | 3 | 5 | −0.84 | 4.65 | <0.001 | 0.8 |
| EG | 1 | 0.5 | 0 | 4 | 1 | ||||
| EPIC-26 (incontinence subscale) | CG | 9 | 1 | 7 | 10 | −0.37 | 3.05 | 0.008 | 0.52 |
| EG | 6 | 3 | 0 | 9 | −1.05 | ||||
| EPIC-26 (irritation/ obstruction subscale) | CG | 4 | 5.5 | 0 | 9 | −0.05 | 3.54 | <0.001 | 0.61 |
| EG | 1 | 1.5 | 0 | 9 | 2.57 | ||||
| EPIC-26 (vitality or hormonal symptom) | CG | 5 | 5 | 0 | 15 | 0.96 | 3.75 | <0.001 | 0.64 |
| EG | 0 | 1 | 0 | 3 | 1.45 | ||||
| EPIC-26 (bowel domain) | CG | 6 | 4.5 | 1 | 11 | −0.08 | 3.54 | <0.001 | 0.61 |
| EG | 1 | 1 | 0 | 9 | 2.22 | ||||
| EPIC-26 (sexual symptom) | CG | 10 | 1 | 6 | 15 | 0.56 | −0.27 | 0.784 | −0.05 |
| EG | 10 | 1 | 0 | 22 | 0.9 | ||||
| EG | 1 | 2.5 | 0 | 8 | 1.18 | ||||
| BDI-II | CG | 5 | 6.5 | 0 | 15 | 0.53 | 2.58 | 0.03 | 0.44 |
| EG | 1 | 2.5 | 0 | 12 | 1.95 | ||||
| myostatin concentration | CG | 91.47 | 33.2 | 45.98 | 162.71 | 0.34 | −1.68 | 0.184 | −0.29 |
| EG | 118.25 | 43.32 | 63.35 | 171.53 | −0.07 |
EG: experimental group; CG: control group; Min: minimum; Max: maximum; Med: median; IQR: interquartile range; Sk: skewness, Z: Z statistic; r: r statistic; p: significance level.